The Department of Health and Human Services (HHS) is now recommending that marijuana be shifted to a lower-risk classification under federal law, a move that could have major implications for medical research into cannabis as well drug legalisation efforts.
The agency is offering a non-binding recommendation to the Drug Enforcement Administration (DEA) to downgrade marijuana from its current status as a Schedule I drug, indicating a treatment with high abuse potential and no medical value, to a lower Schedule III status under the Controlled Substances Act, Bloomberg reports.
